Baseline Characteristics and Outcomes of Patients with Heart Failure Receiving Bronchodilators in the CHARM Programme — Nathaniel M. Hawkins (2010) | RDL Network
Baseline Characteristics and Outcomes of Patients with Heart Failure Receiving Bronchodilators in the CHARM Programme
Article 2010 en
Authors
NH
Nathaniel M. Hawkins
DW
Duolao Wang
MP
Mark C. Petrie
Abstract
1 min read
Bronchodilator use is a powerful independent predictor of worsening HF and increased mortality in a broad spectrum of patients with HF. Whether this relates to a toxic effect of bronchodilators, underlying pulmonary disease, or both is unclear and warrants further investigation.
Paweł Balsam, Krzysztof Ozierański, Agnieszka Kapłon‐Cieślicka, Sonia Borodzicz-Jażdżyk, Agata Tymińska, Michał Peller, Michał Marchel, María G. Crespo‐Leiro, Aldo Maggioni, Jarosław Dróżdż, Grzegorz Opolski, Marcin Grabowski
Marco Canepa, Pier Luigi Temporelli, Andrea Rossi, Andrea Rossi, Lucio Gonzini, Gian Luigi Nicolosi, Lidia Staszewsky, Roberto Marchioli, Aldo Maggioni, Luigi Tavazzi
Robert J. Mentz, Bradley D. Allen, Mary Kwasny, Marvin A. Konstam, James E. Udelson, Andrew P. Ambrosy, Angela J. Fought, Muthiah Vaduganathan, Christopher M. O’Connor, Faı̈ez Zannad, Aldo Maggioni, Karl Swedberg, Robert O. Bonow, Mihai Gheorghiade
Discussion(0)
No comments yet. Be the first to comment.